488 related articles for article (PubMed ID: 28593402)
1. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
[TBL] [Abstract][Full Text] [Related]
2. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
Falzon K; Drimtzias E; Picton S; Simmons I
Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527
[TBL] [Abstract][Full Text] [Related]
3. Intracranial gliomas in neurofibromatosis type 1.
Listernick R; Charrow J; Gutmann DH
Am J Med Genet; 1999 Mar; 89(1):38-44. PubMed ID: 10469435
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome in children with gliomas of the anterior visual pathway.
Tow SL; Chandela S; Miller NR; Avellino AM
Pediatr Neurol; 2003 Apr; 28(4):262-70. PubMed ID: 12849878
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.
Guillamo JS; Créange A; Kalifa C; Grill J; Rodriguez D; Doz F; Barbarot S; Zerah M; Sanson M; Bastuji-Garin S; Wolkenstein P;
Brain; 2003 Jan; 126(Pt 1):152-60. PubMed ID: 12477702
[TBL] [Abstract][Full Text] [Related]
6. Special issues in the management of gliomas in children with neurofibromatosis 1.
Pollack IF; Mulvihill JJ
J Neurooncol; 1996; 28(2-3):257-68. PubMed ID: 8832467
[TBL] [Abstract][Full Text] [Related]
7. Brain gliomas, hydrocephalus and idiopathic aqueduct stenosis in children with neurofibromatosis type 1.
Glombova M; Petrak B; Lisy J; Zamecnik J; Sumerauer D; Liby P
Brain Dev; 2019 Sep; 41(8):678-690. PubMed ID: 31000370
[TBL] [Abstract][Full Text] [Related]
8. [Neurofibromatosis type I (NF1): peculiarities and complications].
Pascual-Castroviejo I
Rev Neurol; 1996 Sep; 24(133):1051-5. PubMed ID: 8755343
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis type 1 and sporadic optic gliomas.
Singhal S; Birch JM; Kerr B; Lashford L; Evans DG
Arch Dis Child; 2002 Jul; 87(1):65-70. PubMed ID: 12089128
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of multidisciplinary management in pediatric low-grade gliomas.
Oh KS; Hung J; Robertson PL; Garton HJ; Muraszko KM; Sandler HM; Hamstra DA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e481-8. PubMed ID: 21470783
[TBL] [Abstract][Full Text] [Related]
11. Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.
Trevisson E; Cassina M; Opocher E; Vicenzi V; Lucchetta M; Parrozzani R; Miglionico G; Mardari R; Viscardi E; Midena E; Clementi M
J Neurooncol; 2017 Sep; 134(2):279-287. PubMed ID: 28577031
[TBL] [Abstract][Full Text] [Related]
12. Neurological complications of neurofibromatosis type 1 in adulthood.
Créange A; Zeller J; Rostaing-Rigattieri S; Brugières P; Degos JD; Revuz J; Wolkenstein P
Brain; 1999 Mar; 122 ( Pt 3)():473-81. PubMed ID: 10094256
[TBL] [Abstract][Full Text] [Related]
13. Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference.
Packer RJ; Iavarone A; Jones DTW; Blakeley JO; Bouffet E; Fisher MJ; Hwang E; Hawkins C; Kilburn L; MacDonald T; Pfister SM; Rood B; Rodriguez FJ; Tabori U; Ramaswamy V; Zhu Y; Fangusaro J; Johnston SA; Gutmann DH
Neuro Oncol; 2020 Jun; 22(6):773-784. PubMed ID: 32055852
[TBL] [Abstract][Full Text] [Related]
14. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
Friedrich RE; Nuding MA
Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
[TBL] [Abstract][Full Text] [Related]
15. Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group.
Ater JL; Xia C; Mazewski CM; Booth TN; Freyer DR; Packer RJ; Sposto R; Vezina G; Pollack IF
Cancer; 2016 Jun; 122(12):1928-36. PubMed ID: 27061921
[TBL] [Abstract][Full Text] [Related]
16. Syndromic and sporadic pediatric optic pathway gliomas: review of clinical and histopathological differences and treatment implications.
Shamji MF; Benoit BG
Neurosurg Focus; 2007; 23(5):E3. PubMed ID: 18004965
[TBL] [Abstract][Full Text] [Related]
17. Non-optic glioma in adults and children with neurofibromatosis 1.
Sellmer L; Farschtschi S; Marangoni M; Heran MK; Birch P; Wenzel R; Friedman JM; Mautner VF
Orphanet J Rare Dis; 2017 Feb; 12(1):34. PubMed ID: 28202035
[TBL] [Abstract][Full Text] [Related]
18. Clinical Presentation and Outcome of Patients With Optic Pathway Glioma.
Robert-Boire V; Rosca L; Samson Y; Ospina LH; Perreault S
Pediatr Neurol; 2017 Oct; 75():55-60. PubMed ID: 28847625
[TBL] [Abstract][Full Text] [Related]
19. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
[TBL] [Abstract][Full Text] [Related]
20. Neurofibromatosis type 1 and the pediatric neurosurgeon: a 20-year institutional review.
Farmer JP; Khan S; Khan A; Ortenberg J; Freeman C; O'Gorman AM; Montes J
Pediatr Neurosurg; 2002 Sep; 37(3):122-36. PubMed ID: 12187057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]